AstroNova Second Quarter 2026 Earnings: US$0.15 loss per share (vs US$0.041 loss in 2Q 2025)

AstroNova (NASDAQ:ALOT) Second Quarter 2026 Results

Key Financial Results

• Revenue: US$36.1m (down 11% from 2Q 2025).
• Net loss: US$1.24m (loss widened by 300% from 2Q 2025).
• US$0.15 loss per share (further deteriorated from US$0.041 loss in 2Q 2025).

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.

All figures shown in the chart above are for the trailing 12 month (TTM) period

AstroNova shares are down 11% from a week ago.

Risk Analysis

You should always think about risks. Case in point, we've spotted 3 warning signs for AstroNova you should be aware of, and 2 of them are significant.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.